Dan Chen

Dan Chen

Auto-generated profile, based on publicly available information

Dan Chen

Medical College of Yanbian University, Jilin, China

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 July 2013 in Science
Verified
Journal Article
Closed access
PDF file
DMDaniel Martinez Molina
Daniel Martinez Molina
RJRozbeh Jafari
Rozbeh Jafari
MIMarina Ignatushchenko
Marina Ignatushchenko
TSTakahiro Seki
Takahiro Seki
ELE. Andreas Larsson
E. Andreas Larsson
PNPär Nordlund
Pär Nordlund
Drug Targeting: Drug efficacy depends on the extent of binding to a cellular target (often a protein) with adverse effects caused by excessive target binding or by off-target binding. Engagement of a target protein inside cells is influenced by the effective drug concentration and by factors that regulate the protein conformation, making it difficult to predict efficacy based on in vitro affinity studies. Martinez Molina et al. (p. 84 ) took advantage of the shift in protein thermal stability caused by drug binding to directly monitor target protein-drug interactions in cells. The method was used to monitor drug target engagement in cancer cells and in mouse livers and kidneys.

2 January 2019 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
JDJerzy M. Dziekan
Jerzy M. Dziekan
HYHan Yu
Han Yu
DCDan Chen
Dan Chen
LDLingyun Dai
Lingyun Dai
GWGrennady Wirjanata
Grennady Wirjanata
PNPär Nordlund
Pär Nordlund
A cellular thermal shift assay (CETSA) protocol identifies and resolves antimalarial drug targets in P. falciparum .

1 August 2017 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
DCDan Chen
Dan Chen
AJAnna Jansson
Anna Jansson
DSDaniel Sim
Daniel Sim
ALAndreas Larsson
Andreas Larsson
PNPär Nordlund
Pär Nordlund
Thymidylate synthase (TS) is the sole enzyme responsible for de novo biosynthesis of thymidylate (TMP) and is essential for cell proliferation and survival. Inhibition of human TS (hTS) has been extensively investigated for cancer chemotherapy, but several aspects of its activity and regulation are still uncertain. In this study, we performed comprehensive structural and biophysical studies of hTS using crystallography and thermal shift assay and provided the first detailed structural information on the conformational changes induced by ligand binding to the hTS active site. We found that upon binding of the antifolate agents raltitrexed and nolatrexed, the two insert regions in hTS, the functions of which are unclear, undergo positional shifts toward the catalytic center. We investigated the inactive conformation of hTS and found that the two insert regions are also involved in the conformational transition between the active and inactive state of hTS. Moreover, we identified a ligand-binding site in the dimer interface, suggesting that the cavity in the dimer interface could serve as an allosteric site of hTS to regulate the conformational switching between the active and inactive states. On the basis of these findings, we propose a regulatory mechanism of hTS activity that involves allosteric regulation of interactions of hTS with its own mRNA depending on cellular demands for TMP.

4 June 2013 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
ELE. Andreas Larsson
E. Andreas Larsson
AJAnna Jansson
Anna Jansson
FNFui Mee Ng
Fui Mee Ng
STSiew Wen Then
Siew Wen Then
RPResmi Panicker
Resmi Panicker
PNPär Nordlund
Pär Nordlund

17 October 2018 in ChemBioChem
Verified
Journal Article
Open access
PDF file
DCDan Chen
Dan Chen
Matthias GehringerMatthias Gehringer
Matthias Gehringer
SLSonja Lorenz
Sonja Lorenz
The ubiquitin system regulates countless physiological and disease‐associated processes and has emerged as an attractive entryway for therapeutic efforts. With over 600 members in the human proteome, ubiquitin ligases are the most diverse class of ubiquitylation enzymes and pivotal in encoding specificity in ubiquitin signaling. Although considerable progress has been made in the identification of small molecules targeting RING ligases, relatively little is known about the “druggability” of HECT (homologous to E6AP C terminus) ligases, many of which are critically implicated in human pathologies. A major obstacle to optimizing the few available ligands is our incomplete understanding of their inhibitory mechanisms and the structural basis of catalysis in HECT ligases. Here, we survey recent approaches to manipulate the activities of HECT ligases with small molecules to showcase the particular challenges and opportunities these enzymes hold as therapeutic targets.

1 June 2013 in Journal of Lipid Research
Verified
Journal Article
Open access
PDF file
SLSing Mei Lim
Sing Mei Lim
DCDan Chen
Dan Chen
HTHsiangling Teo
Hsiangling Teo
ARAnnette Roos
Annette Roos
AJAnna Elisabet Jansson
Anna Elisabet Jansson
PNPär Nordlund
Pär Nordlund
Lipocalin prostaglandin D synthase (L-PGDS) regulates synthesis of an important inflammatory and signaling mediator, prostaglandin D2 (PGD2). Here, we used structural, biophysical, and biochemical approaches to address the mechanistic aspects of substrate entry, catalysis, and product exit of this enzyme. Structure of human L-PGDS was solved in a complex with a substrate analog (SA) and in ligand-free form. Its catalytic Cys 65 thiol group was found in two different conformations, each making a distinct hydrogen bond network to neighboring residues. These help in elucidating the mechanism of the cysteine nucleophile activation. Electron density for ligand observed in the active site defined the substrate binding regions, but did not allow unambiguous fitting of the SA. To further understand ligand binding, we used NMR spectroscopy to map the binding sites and to show the dynamics of protein-substrate and protein-product interactions. A model for ligand binding at the catalytic site is proposed, showing a second binding site involved in ligand exit and entry. NMR chemical shift perturbations and NMR resonance line-width alterations (observed as changes of intensity in two-dimensional cross-peaks in [1H,15N]-transfer relaxation optimization spectroscopy) for residues at the Ω loop (A-B loop), E-F loop, and G-H loop besides the catalytic sites indicate involvement of these residues in ligand entry/egress.